Pricing Log in Create free account
Friday 6 November 2026 Export TAK’s income statement to Excel — free account

Takeda Pharmaceutical Co.

TAK Healthcare Drug Manufacturers Specialty & Generic

Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025.

Revenue
+1.71%
EPS
−4.35%
Free cash flow
+54.9%
Total debt
−7.28%

Quarter to September 2026, against a year earlier

21.25 0.19 +0.90%
Market cap
$67.7B
P/E
32.0×
Fwd P/E
—
Dividend yield
1.45%
F-score
4/9
Altman Z
1.03
Beneish M
−2.65
Dividend safety
25/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Takeda Pharmaceutical Co. (TAK) Current ratio

Alert me on Current ratio

Takeda Pharmaceutical Co.'s current ratio at the end of the quarter to 30 September 2026 was 1.2×, up 0.1× from fiscal 2026 (1.1×). Over the past ten years it has ranged from 0.9× (fiscal 2017) to 1.6× (fiscal 2016); the current reading is higher than 33% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2026 1.1× 8.49%
FY2025 1.0× (9.06%)
FY2024 1.1× 14.48%
FY2023 1.0× (20.06%)
FY2022 1.2× (21.00%)
FY2021 1.5× 34.81%
FY2020 1.1× (6.59%)
FY2019 1.2× (16.94%)
FY2018 1.5× 58.52%
FY2017 0.9× (42.42%)

Quarterly newest first

Period Current ratio Change
Sep 2026 1.2× 1.03%
Jun 2026 1.1× (4.56%)
Dec 2025 1.2× (12.53%)
Sep 2025 1.4× 17.85%
30 more quarters

Against its own ten years

Low 0.9× High 1.6×
Ten-year median 1.2×
Current reading's percentile 33

Current ratio against peers

Company Current ratio
UTHR United Therapeutics Corporation compare 4.7×
ZTS Zoetis Inc. compare 3.1×
ELAN Elanco Animal Health Incorporated compare 2.1×
NBIX Neurocrine Biosciences, Inc. compare 2.0×
RDY Dr. Reddy's Laboratories Ltd compare 1.9×
VTRS Viatris Inc. compare 1.6×
TAK Takeda Pharmaceutical Co. 1.2×
TEVA Teva Pharmaceutical Industries Ltd. compare 0.9×
HLN Haleon PLC Sponsored ADR compare 0.7×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on TAK